Eryby gnnouolr'o

2.2016

Towers

l^his js to inforrn you lhat,

the Board of Direltors of the
Company at its mr rting held
c)()nstdered anrj aoc oved
today
the Unaudited Financiai nesrfts (provisional
ernded 31.12.2015
for the quarter

T'hanking you.
Yours faithfullv.
fonVEtUM$ ftE-il

IMITED.

(Company Secretary

UEI{II,S RT]MEDIES
Corporate Office

uM

5 | -52, Industrial Area, phase- .,

Panchkula (Hry.) t34 | 13, India

Regd. Office

-52, Industrial Area,

+9l-| 72-3933094, 393

Tel. :

Unit-ll

SCO 857, Cabin No. 10, 2nd Floor, NA(],

Manimajra, Chan,Jigarh (U.I) 160l0 | , India

ODY
RNAITIONAL

Stress Reliever

(Hry.) l 34l l 3, India

Fu : + 9 | - | 72-2565566

2565577,

Hill Top Industrial Estate.

Bhatoli Kalan, Baddi (H.l?i I
Tel. : +91-1795-302t00, 302

Unit-V:
VENUS PHARMA GmbIJ
AM Bahnhof t-3, D-59368.

EPlf Phce-1, (Extn.),

lndia
, 3021 07, Fax : +

9 |-|

795-21 | 272

Germany

with Liver Detoxifier & Antioxidant property

A German Technology

VRL/SEC/EXCH

GE

10"02.2016

National Stock

change of Indi

Ltd.
5'n Floor , Exchang
Bandra (E),
Mumbai- 400 051

Plaza

Sub: Submission

Unaudited

Fi,na

ial resirlts as on 31.'12.201!i

Dear Sir/Madam,
Please find e
herewith copy of U
with limited review
rt for the quarte
record by the Boa,r of Directors at its m
Kindly ack

the receipt.

Thanking you.

Yours faithfully1LUVilTED,
retary)

(Company Secre

rv)

UEl{US REMEDIES UM
Corporate Office

5 | -52, Industrial Area, phase_ l.

Panchkula (Hry.) 134 | t3, India

Regd. Office

5l-52, lndustrialArea, phae-|, panchkula(Hry.) l34l 13, India

e | - | 72-3e3 30e4, 3 e3 30e0, zsess)t, i, i,i,
+ g l_' i iiisasxo

rel. : +

Unit-ll

SCO 857, Cabin No. 10, 2nd Floor, NAC,

Manimajn, Chandigarh (U.T) l50l 0 l . India

ffiH,*".

email : in

ctN No.

Jharmajri EplB phce_1, (Exrn.),

| 73205, India
, 302 t0t, 302 t07, Fax : +9t _]95-21
t272
,

M
lNl

7
'tdtinqe Ua.lru?to I
Stress Reliever Herbal Candy

l)

o DY

VENUS PHARMA GmbIJ

ONAL

Stress Reliever

AM Bahnhof l-3, D-S93,58, Werne, Germany

Liver

Detfxifier & Antioxidant property

A German Technology

UNAUDITED
rAL RESqLTS (PROVtstoNAL)
FOR THE QUARTER ENDED
31st DEGEMBER,

201S

No

( Rs, In Millions)

Quartor Ended on

Nine Months

ARTICLILARS

on

Part

N;t sales/

l""or" fr",

unaudited unaudttect

(a) Net Sales ( Net of Excise

(b) Other Operating lncome

Expenses
(a) Cost of material
(b) Changc in inventories of
& stock in trade
(c) Employee benefits
(d) Depreciation & amortisal
(e) Other expenses
Total expense
ProfiU (Loss) from oDe

and exceptional items ( 1-2)

4
6
7
8
q
'10
11

12
13
14
1t
16

Other income
Profit/ (Loss) before finance
Finance Costs
Profit / (Loss) after finance
Exceptional items
Profit / (Loss) from ordinary
Tax expense

1008.66

966.76
17.41

(Net)

gae,ii

r.oi'a

3513.53

4497.45

r,rii;.li

4,518.75

2008.17

2,643.89

87.s1

65.28

200.46

272.55

50.78

654.64

ished r;oods, work in progress

(7.s8)l 37.481

21.3

61.s1 sa.os]
101.06 83.00i
147.58 167.881
9s7.21 951.41]
102.23 104.n1

expenso

before other incomo, finance

EBIDTA ( 3+2(d))
c

year

Ended on

30t09t2015 31t12t2014 3i1t,12t2015 31t12t2014

31103t201s
Audited

Total Income from

Ended

and exceptional items

203.3
1.19
,t03.42
87.3T
16.05
o.Oo
16.05
0.00

(3

but before exceptional items

s-6)

before tax ( 7+B)

Profit / (Loss) from ordinary

after tax (9-10 )
Extraordinary items ( net of
expens0)
Net profiU (Loss) for the
( 11-121
Paid up Equity Share CaDital
value of Rs. 10/- per share)
Reserves excluding revalua
reserues
E.P.S - Basic not annualised f
the qtr
- Annualised
Part - ll
Public Shareholding

276.5s

447.41

482.s7

667.70

3,055.70

4,096.83

474.24

421.92

750.83

869.33

187.23', 575.4s

r.rs]
z.gsl
10s.39 276.061
ae.sz] 260.521
z,t.nz)
O.o0l

3.28

5.46

477.52

427.38

2so.sl

407.03

226.ss

20.35

o.o0

00.00

226.95

20.35

o.oo

25.13
45.48
0.00
45.48
'114.42

4 547.93
3.97
3.97

- Number of Shares
- Percentage of Shareholding
z

Promoters and promoter

a) Pledged as collateral
; Number of Shares
- Percentage of shares (as a
holding of promoter and
- Percentage of sharos (as
a%

b)

Non-Encumbored
- Number of Sharos
- Percentage of shares (as a
%
holding of promoter and
- Percentage of shares (as
a%

zzr

isss
67.40

the total share

3730000
100.00

the tollal share caDital

a't.t,

32.60

the total share

group
the total share capital

po00o

0.00

02.68

00.00

p0.81

00.00

REMEDIES Lil'i'ilTED

r\tr'U I \Jr(

r\

VENU
Notes:

The above fi

record at the

2,

r,l.Results were reviewed by

the Audit Connmittee and taken
on
lVleeting on Febrfuary 10,20i6.

The Comprany

to only one selllment i.e. "pharmaceuticar

Formurations,,

For and on behalf of lSoard

of Directors

ril'vlAN

&

Date: 10.02.2016
DIN: 00435503

VEl'lUS REMEDTES UM

Corporate Office

Unit-l

5 | -52, Industrial Area, phase- ,,

Panchkula (Hry.) 134 | t3, India

Regd. Office

phase-t, panchkuta (Hry)

t34 | t3, India
:1.-52: I'9ysJla] {rea,
| 7 Z-39330e4, 393 3090, zS es
t,
+ e | _' i t i_iS ssSee

Tet. : + 9 | -

Unit-ll

M
INT

OI

DY

IIONAL

Stress Reliever withr Liver Detoxifier &

i_,

tate, Jharmajri EplB phce_|, (Extn ),

(H.P) t73205, India
t00 302t0t, J02107, Fax : +gt_t7gi_27 t27Z
VENUS PHARMA GmbH
AM Bahnhof l-3, D-593,58, Werne, Germanv

Antioxidant property
A German Technology

J.K. JAIN & ASSOCIATES

CHARTERED ACCOANTANTS

S.C.O. 1132-33, Sector 22-8, CHANDIGARH-160 022

0172-270 4536 37 Fax : 0172-270 4537

E-mail : jkcops@rediflmail.com

REVIEW REPORT
The Board of Directors,
Venus Remedies Limited
5I-52, Industrial Atea, Phase-I
Panchkula

We have reviewed the accompanying statement of un-audited Financial Results of Venus

Remedies Limited for the Quarter / Nine Months ended 31.12.2015. This statement is the
responsibilrty of the Company's Management and has been approved by the Board of
Directors/Committee of Board Directors. Our responsibility is to issue a report on these financial
statements based on our review.
We conducted our review in accordance with the Standard on Review Engagement (SRE) 2400,
'Engagements to Review financial statements' issued by the Institute of Chartered Accountants
of India. This standard requires that we plan and perform the review to obtain moderate
assurance as to whether the financial statements are free of material misstatement. A review is
limited primarily to inquiries of company personnel and analytical procedures applied to
financial data and thus provides less assurance than an audit. We have not performed an audit
and accordingly, we do not express an audit opinion.
Based on our review conducted as above, nothing has come to our attention that causes us to
believe that the accompanying statement of un-audited Quarterly/ Nine Monthly financial results
prepared in accordance with applicable accounting standards and other recognized accounting
practices and policies has not disclosed the information required to be disclosed in terms of
Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulation 2015
including the manner in which it is to be disclose4 or that it contains any material misstatement.

for J. K. Jain & Associates,

M.No.537795
FRN No.004025N
Date :10.02.2016
Place : Chandigarh

Delhi office : 503 504, Chiranjiv Tower, 43, Nehru Place, New Delhi-l10019